Survival analysis of multivariate failure time data addresses the statistical modelling of multiple related event times observed on the same experimental unit or within clusters. Such data arise in ...
Low MRD levels during and after therapy were associated with longer progression-free survival (PFS) and overall survival (OS; P < .0001). Median PFS is estimated at 68.7, 40.5, and 15.4 months for low ...
Dasatinib (D) in combination with weekly (w) paclitaxel (P) for patients (pts) with metastatic breast carcinoma (MBC): A phase I/II study. Background: In the absence of curative treatment for the ...
A retrospective analysis compared the overall survival outcomes for SIRT and PHP in patients with metastatic uveal melanoma.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results